B j a furr (54 risultati)

Paperback. Condizione: As new. jacketcondition. xvi + 420 pp. Cancer Drug Discovery and Development. book.

Hardcover. Condizione: Very Good. No Jacket. 0702011363. Brown cloth hardcover, with gold lettering on the spine and front board, from closed Astra Zeneca company library. Lending record shows this book has been borrowed twice. 608 pages, index, illustrated with charts, tables and diagrams. Contents page edges are tanned, otherwise clean, binding tight. Book.…

Hardcover. Condizione: Near Fine. 3764371994. Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed, tiny bump on 1 corner. 194 pages, index, illustrated with charts, tables and diagrams. Many breast tumours are dependent upon oestrogen for their growth. Hormone therapy has progressed from the irreversible destruction of endocrine glands to the use of drugs that reversibly suppress oestrogen synthesis or action. The inhibition of oestrogen synthesis is most readily achieved by inhibiting the final step in the pathway of oestrogen biosynthesis, the reaction which transforms androgens into oestrogens by creating an aromatic ring in the steroid molecule (hence the enzyme's trivial name, aromatase).Whereas the first aromatase inhibitors to be used therapeutically could be shown to produce drug-induced inhibition of the enzyme and therapeutic benefits in patients with breast cancer, they were not particularly potent and lacked specificity. Second generation drugs were developed and most recently third generation inhibitors have evolved which possess remarkable specificity and potency. Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy. Contents as new, clean, tight and bright. Book.…

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

hardcover. Condizione: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority.

Condizione: Used. pp. x + 189 2nd Revised Edition.

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condizione: Used. pp. x + 189.

Condizione: Used. pp. x + 189.

Couverture rigide. Condizione: bon. R160225216: 2002. In-8. Relié. Bon état, Couv. convenable, Dos satisfaisant, Intérieur frais. XIV + 420 pages - ouvrage en anglais - nombreuses figures en noir et blanc dans le texte - tampon sur la page de garde et sur la page de titre. . . . Classification Dewey : 420-Langue anglaise. Anglo-saxon.…

Condizione: As New. Unread book in perfect condition.

Condizione: Used. pp. 182 1st Edition.

Condizione: New.

Condizione: Used. pp. 440.

Condizione: Used. pp. 182.

Condizione: New. In English.

Condizione: Used. pp. 440 Illus.

Condizione: New. This book describes the principles underlying targeted hormonal treatments, assesses the actions of new and established agents, and illustrates the new applications of hormonal chemoprevention for breast cancer. Editor(s): Jordan, V. Craig; Furr, B. J. A. Series: Cancer Drug Discovery and Development. Num Pages: 420 pages, 36 black & white illustrations, biography. BIC Classification: MFGM; MJCL2; MJG. Category: (P) Professional & Vocational. Dimension: 233 x 156 x 24. Weight in Grams: 650. . 2009. Softcover reprint of the original 1st ed. 2002. Paperback. . . . .…

Condizione: Used. pp. 182.

Paperback. Condizione: Brand New. 2nd revised edition. 189 pages. 9.25x6.50x0.75 inches. In Stock.

hard bound. Condizione: Sehr gut. Gebraucht - Sehr gut about this book: Many breast tumours are dependent upon oestrogen for their development and continued growth. Over the last 25 years hormone therapy has progressed from the irreversible destruction of endocrine glands to the use of drugs that reversibly suppress oestrogen synthesis or action. The inhibition of oestrogen synthesis is most readily achieved by inhibiting the final step in the pathway of oestrogen biosynthesis, the reaction which transforms androgens into oestrogens by creating an aromatic ring in the steroid molecule (hence the enzyme's trivial name, aromatase). Whereas the first aromatase inhibitors to be used therapeutically could be shown to produce drug-induced inhibition of the enzyme and therapeutic benefits in patients with breast cancer, they were not particularly potent and lacked specificity. However, second-generation drugs were developed and most recently third-generation inhibitors have evolved which possess remarkable specificity and potency. Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy. Written for: Scientific libraries, pharmaceutical industry, researchers and clinicians; postgraduate students.…

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Many breast tumours are dependent upon oestrogen for their development and continued growth. Over the last 25 years hormone therapy has progressed from the irreversible destruction of endocrine glands to the use of drugs that reversibly suppress oestrogen synthesis or action. The inhibition of oestrogen synthesis is most readily achieved by inhibiting the final step in the pathway of oestrogen biosynthesis, the reaction which transforms androgens into oestrogens by creating an aromatic ring in the steroid molecule (hence the enzyme's trivial name, aromatase).Whereas the first aromatase inhibitors to be used therapeutically could be shown to produce drug-induced inhibition of the enzyme and therapeutic benefits in patients with breast cancer, they were not particularly potent and lacked specificity. However, second-generation drugs were developed and most recently third-generation inhibitors have evolved which possess remarkable specificity and potency. Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy.…

Condizione: Used. pp. 440.

Condizione: Sehr gut. Zustand: Sehr gut | Seiten: 436 | Sprache: Englisch | Produktart: Bücher | In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying targeted hormonal treatments, assess the actions of new and established agents, and illustrate the new applications of hormonal chemoprevention for breast cancer. Topics range from preclinical and clinical antiestrogens to the inhibition of estrogen synthesis and the effects of androgen withdrawal. A wide variety of proven and new agents are discussed-antiestrogens, including aromatase inhibitors (anastrozole, letrozole, and others), SERMs (tamoxifen, raloxifene, and others), and such antiandrogenic strategies as goserelin and bicalutamide.…

Taschenbuch. Condizione: Neu. Hormone Therapy in Breast and Prostate Cancer | Jordan V. Craig (u. a.) | Taschenbuch | Cancer Drug Discovery and Development | xiv | Englisch | 2009 | Humana | EAN 9781607614715 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …